Discussion
Combining spinal fluid biomarkers associated with Alzheimer’s disease with levels of neurofilament light chain (NfL), a biomarker of nerve damage, may improve the diagnosis of people with amyotrophic lateral sclerosis (ALS) and predict their long-term outcomes, a study suggests. For example, people with ALS who test positive for the…